Project Grant R35GM166251
- The National Institute of General Medical Sciences awarded The Regents of the University of California, San Francisco $123,147 on May 13, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate jumbo bacteriophage infection mechanisms and their potential as therapeutics against antibiotic-resistant bacteria. The research, conducted under the K99/R00 pathway, examines how FKZ-like jumbophages with genomes exceeding 200 kilobases evade bacterial immune...
- The National Institute of General Medical Sciences awarded Georgia TECH Research Corp $421,857 under the Biomedical Research and Research Training program (CFDA 93.859) on August 1, 2026. The award funds development of quantum and nanosensing technologies combined with artificial intelligence to investigate autophagic pathways and lysosomal dysregulation in living systems. The research employs precision synthetic chemistry, nanoscale engineering, spectroscopy, and machine learning to monitor...
- The National Institute of General Medical Sciences awarded Georgia Southern University Research & Service Foundation Inc. $142,000 on July 16, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational tools for analyzing actin filament architecture in cryo-electron tomography (cryo-ET) images. The project addresses a critical bottleneck in structural biology: current methods for extracting quantitative morphological data from cryo-ET images...
- The National Institute of General Medical Sciences awarded Georgia TECH Research Corp $432,850 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct computational research on protein dynamics and allostery in biomedically important enzymes. The work uses biomolecular simulations to explore conformational dynamics, allosteric regulation, and catalytic function in three enzyme systems: PRIA and TRPC (central to tryptophan biosynthesis and potential...
- The National Institute of General Medical Sciences awarded Health Research, Inc. Wadsworth Center $386,003 on August 1, 2026, to fund research on mechanisms of bacterial defense against conjugative plasmids and their phages under the Biomedical Research and Research Training program (CFDA 93.859). The research addresses antibiotic resistance by investigating how bacteria defend against conjugative plasmids—which spread resistance genes across bacterial populations—and plasmid-dependent phages...
- The National Institute of Allergy and Infectious Diseases awarded Georgia State University Research Foundation Inc. $795,962 on August 4, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate how gut microbiota composition influences respiratory viral infection outcomes and alveolar macrophage function. The research examines the protective mechanisms by which segmented filamentous bacteria (SFB) colonization in the intestine confers resistance to severe...
- The National Institute of General Medical Sciences awarded the Trustees of Boston University $437,036 on June 1, 2026, for genomic enzymology research to decipher bacterial membrane-associated glycan assembly under the Biomedical Research and Research Training program (CFDA 93.859). The funded work identifies and assigns functional signatures for substrate specificity in phosphoglycosy transferase and glycosyltransferase enzymes to enable glycan composition inference at the protein sequence...
- The National Institute of General Medical Sciences awarded the College of William and Mary $571,875 on September 5, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct functional characterization of novel phage satellites in mycobacteria. The research will advance fundamental understanding of mycobacterium phage satellite biology—mobile genetic elements that parasitize helper phages to complete their life cycles. The college's laboratory discovered...
- The National Institute of General Medical Sciences awarded Oklahoma State University $373,960 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on genome evolution and design in small, single-stranded DNA phages (Microviridae). The award is structured as a Project Grant with a period of performance running through August 31, 2031. Work is performed in Oklahoma City, Oklahoma. The National Institute of General Medical Sciences...
- The National Institute of General Medical Sciences awarded the University of Georgia Research Foundation, Inc. $393,673 on July 16, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop a predictive framework for zoonotic disease emergence spanning wildlife epizootics, human spillover, and outbreak amplification. The recipient will integrate large-scale host-virus networks, ecological and demographic data, and advanced statistical and machine learning...
The National Institute of General Medical Sciences awarded Georgia State University Research Foundation Inc. $434,729 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on bacteriophage gene essentiality and infection dynamics across environmental contexts. The award funds research to map phage gene function and track infection dynamics using complementary molecular approaches. The work will exploit DNA mismatch-repair deficient hosts to create full mutant libraries of bacteriophages, generating near-saturated mutational landscapes to identify differentially essential versus non-essential phage genes and determine how gene essentiality varies across bacterial strains and environments. The research will also adapt single-cell RNA sequencing to capture transcriptional programs of both bacteria and phages within individual infected cells, revealing how bacterial physiological state influences susceptibility to phage infection and how phages retune their transcription to exploit different host environments. Integration of these tools will define how environmental and host factors shape phage gene function and how bacterial heterogeneity alters infection outcomes, addressing knowledge gaps in phage-host interactions and bacterial transcriptional heterogeneity. The award is classified as a Project Grant. Period of performance extends from September 1, 2026, through August 31, 2031. Work is performed in Atlanta, Georgia. Principal investigator is James Gurney.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $434.7k | 8/28/26 |